Syrris sponsor 1st Flow Chemistry Symposium in Brazil
16 November 2011 | By kdm communications limited
Syrris, is pleased to be a sponsor of the 1st Flow Chemistry Symposium (1st FCS)...
List view / Grid view
News
Data shows effects of Effient in STEMI patients
16 November 2011 | By Eli Lilly and Company
An analysis of the TRITON-TIMI 38 trial presented...
Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union
15 November 2011 | By Amgen
The EC has approved a variation to the marketing authorization for Vectibix®...
Abbott statement on the results of the AIM-HIGH study presented at AHA 2011
15 November 2011 | By Abbott
Final results were presented today from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study...
SATURN demonstrated effect of intensive statin treatment on reducing atherosclerosis
15 November 2011 | By AstraZeneca
Data presented at this year’s AHA reinforces the established efficacy profile of CRESTOR...
Gilead Sciences finalizes agreement with Tibotec Pharmaceuticals
15 November 2011 | By Gilead Sciences
Gilead Sciences, Inc. has entered into a license agreement with Tibotec Pharmaceuticals...
Avacta Analytical partners with UCL as sponsor of their EPSRC Centre for Innovative Manufacturing
14 November 2011 | By kdm communications limited
Avacta Analytical is partnering with University College London as an industrial sponsor...
Dramatic increase in diabetes prevalence calls for action
14 November 2011 | By Novo Nordisk
On World Diabetes Day, new numbers on the prevalence of diabetes have been released by the IDF...
Genzyme announces successful Phase III results for Alemtuzumab (LEMTRADA) in multiple sclerosis
14 November 2011 | By Sanofi
The Phase lll CARE-MS ll trial met both of its co-primary endpoints...
Data from TRACER study of Vorapaxar, Merck’s investigational medicine for Cardiovascular Disease, presented at AHA
13 November 2011 | By Merck
TRACER did not achieve primary endpoint...
New data presented on Phase 3 trial of ELIQUIS® (apixaban)
13 November 2011 | By Pfizer
Bristol-Myers Squibb Company and Pfizer Inc. announced the results of the Phase 3 ADOPT trial...
Merck highlights pipeline progress and showcases novel innovations at R&D and Business Briefing
11 November 2011 | By Merck
Merck is hosting a R&D and Business Briefing...
Lundbeck and Otsuka Pharmaceutical sign historic agreement to deliver innovative medicines targeting psychiatric disorders worldwide
11 November 2011 | By H. Lundbeck A/S (Lundbeck)
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced a development and commercialisation agreement for up to five products in the psychiatry field, including aripiprazole depot formulation and OPC-34712 from Otsuka and up to three highly innovative earlier stage projects from Lundbeck.
Sanofi and Regeneron report positive preliminary Phase 2 program results
10 November 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program...
Syrris process chemistry systems support scale-up experiments in Brazil
10 November 2011 | By kdm communications limited
Zirkon Industria e Comercio Ltda in Brazil relies on an Atlas Calorimeter...
